This announcement is a separate document:
艾德生物:监事会关于公司2023年限制性股票激励计划首次授予第一个解除限售期可解除限售激励对象名单的核查意见
Ed Biotech: Supervisory Board\'s Review Opinions on the Company\'s 2023 Restricted Stock Incentive Plan for the First Time Granting the First List of Incentives to Lift the Sales Restriction Period
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.